RealSeq Biosciences Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$5M
- Investors
-
17
RealSeq Biosciences General Information
Description
Developer of RNA fragmentomics technology designed to offer real-time detection of disease for improving diagnosis and treatment. The company's technology is used for biomarker discovery, liquid biopsy, and single-cell analysis in the fields of cancer and infectious diseases, and bioinformatics for analyzing degradation, splicing, mutations, and modifications, enabling clients to improve patient outcomes through innovative RNA-based services.
Contact Information
Website
www.realseq.comCorporate Office
- 2125 Delaware Avenue
- Suite B
- Santa Cruz, CA 95060
- United States
Corporate Office
- 2125 Delaware Avenue
- Suite B
- Santa Cruz, CA 95060
- United States
RealSeq Biosciences Timeline
RealSeq Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Seed Round | 01-Mar-2024 | $5M | Completed | Generating Revenue | ||
| 5. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 4. Grant | 13-Oct-2023 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jun-2022 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2018 | $2.02M | Completed | Startup | ||
| 1. Grant | 01-Jan-2019 | $2.6M | Completed | Startup |
RealSeq Biosciences Comparisons
Industry
Financing
Details
RealSeq Biosciences Competitors (2)
One of RealSeq Biosciences’s 2 competitors is Exai Bio, a Venture Capital-Backed company based in Palo Alto, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Exai Bio | Venture Capital-Backed | Palo Alto, CA | ||||
| CD Genomics | Corporation | Shirley, NY |
RealSeq Biosciences Signals
RealSeq Biosciences Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel Star Ventures | Angel Group | Minority | ||
| Berkeley Angel Network | Angel Group | Minority | ||
| Charleston Angel Partners | Angel Group | Minority | ||
| Chemical Angel Network | Angel Group | Minority | ||
| MEDA Angels | Angel Group | Minority |
RealSeq Biosciences FAQs
-
When was RealSeq Biosciences founded?
RealSeq Biosciences was founded in 2019.
-
Where is RealSeq Biosciences headquartered?
RealSeq Biosciences is headquartered in Santa Cruz, CA.
-
What is the size of RealSeq Biosciences?
RealSeq Biosciences has 9 total employees.
-
What industry is RealSeq Biosciences in?
RealSeq Biosciences’s primary industry is Diagnostic Equipment.
-
Is RealSeq Biosciences a private or public company?
RealSeq Biosciences is a Private company.
-
What is RealSeq Biosciences’s current revenue?
The current revenue for RealSeq Biosciences is .
-
How much funding has RealSeq Biosciences raised over time?
RealSeq Biosciences has raised $5M.
-
Who are RealSeq Biosciences’s investors?
Angel Star Ventures, Berkeley Angel Network, Charleston Angel Partners, Chemical Angel Network, and MEDA Angels are 5 of 17 investors who have invested in RealSeq Biosciences.
-
Who are RealSeq Biosciences’s competitors?
Exai Bio and CD Genomics are competitors of RealSeq Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process